Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, "Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit ...

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...

Discover why Hims & Hers Health's subscriber growth, profitability, and telehealth expansion make it a strong buy with a ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Novo Nordisk urges customers to purchase medications solely from authorized pharmacies with valid prescriptions after a theft ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

Novo Nordisk (NVO) will be forced to lower employee bonuses in its home country, Denmark, as the company doubles down on a ...

Eli Lilly and Company LLY is a key player in the diabetes and obesity drug market, mainly due to the significant popularity ...

In the wake of weight-loss drugs and the rising importance of health, the iconic cultural brand must double down on its roots ...

Uagnda's Dei BioPharma Ltd has announced that the U.S. Food and Drug Administration has accepted the development plan for two of its novel biological drugs, liraglutide and semaglutide, which are used ...